Subutex

Reduce Withdrawal Symptoms & Cravings: The FDA approved Subutex in 2002 to treat opiate dependence. Of the 2.4 million U.S. citizens addicted to opiates, Subutex has become a very popular choice in opiate addiction treatment.


What to Expect: Subutex is a tablet administered sublingually as a single daily dose. At the patient’s first visit for treatment, the dose of Subutex should be administered at least 4 hours after the patient last used opioids or preferably when moderate objective signs of opioid withdrawal appear. From there, patient and doctor can work together to find the right time to taper off Subutex.

Written by Dr. Raafat Girgis

Posted on January 1, 2017

How It Works: The Buprenorphine in Subutex can fill and activate opioid receptors in the brain. Once you activate these receptors sufficiently, you stop feeling opiate withdrawal. Buprenorphine is considered “sticky,” which means it will bump other drugs out of opioid receptors and “stick” on these opioid receptors very well. If you took Buprenorphine at the same time as heroin, the Buprenorphine would bump out all of the heroin and stick on the receptors, not allowing the heroin to have its normal effect. Also, Buprenorphine Is a partial agonist – it has a limited ability to activate opioid receptors. It can fill them up enough to stop someone from feeling sick, but it cannot activate these receptors enough to cause euphoria.

Of the 2.4 million U.S. citizens addicted to opiates, Subutex has become a very popular choice in opiate addiction treatment.

What It's For: Subutex works to eradicate opiates’ influence on the brain, and allow opiate addicted users to discontinue use without experiencing painful withdrawal symptoms or struggling with drug cravings.

How to Get It: To learn more about Subutex contact the Landon Institute for a complimentary consultation, where Board Certified Physicians qualified to treat alcohol and opioid dependent patients can determine if Subutex is right for you or your loved one.

Subutex is a tablet administered sublingually as a single daily dose. At the patient’s first visit for treatment, the dose of Subutex should be administered at least 4 hours after the patient last used opioids or preferably when moderate objective signs of opioid withdrawal appear.

You're Not Alone

At our beautiful institute in Newport Beach, California, The Landon Institute provides nationally recognized evidence-based outpatient treatment programs for addiction, rehabilitation, and recovery. Our Board Certified Physicians are extensively experienced in addiction recovery and rehabilitation. We believe in a comprehensive, whole-recovery approach to overcoming chemical and/or alcohol dependency that focuses on all three factors of health that addiction affects: physical, mental and emotional health.

We're Ready to Help Now!
Contact Us

CONTACT US